We estimate that the CEO of Medtronic plc ($MDT), Geoff Martha, received a compensation of $22,940,252 in 2026. This is an increase of 7.41% from an estimated $21,240,058 in 2025.
These estimates are based on a new DEF14A filing, filed with the SEC on August 17, 2026. Note that parsing errors may occur.
You can track $MDT on Quiver Quantitative's $MDT stock dashboard.
$MDT Stock Insider Trading Activity
$MDT Stock insiders have traded $MDT stock on the open market 8 times in the past 6 months. Of those trades, 0 have been purchases and 8 have been sales.
Here’s a breakdown of recent trading of $MDT stock by insiders over the last 6 months:
- HARRY SKIP KIIL (EVP & President Cardiovascular) has made 0 purchases and 7 sales selling 56,713 shares for an estimated $5,469,182.
- MATTHEW R. WALTER (SVP, Chief HR Officer) sold 3,102 shares for an estimated $257,931
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$MDT Stock Congressional Stock Trading
Members of Congress have traded $MDT stock 4 times in the past 6 months. Of those trades, 1 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $MDT stock by members of Congress over the last 6 months:
- REPRESENTATIVE RICHARD MCCORMICK sold up to $15,000 on 07/30.
- REPRESENTATIVE GILBERT RAY CISNEROS, JR. sold up to $15,000 on 05/15.
- SENATOR ALAN ARMSTRONG purchased up to $15,000 on 03/27.
- REPRESENTATIVE KEVIN HERN sold up to $50,000 on 03/20.
To track congressional stock trading, check out Quiver Quantitative's congressional trading dashboard. You can access data on congressional stock trades through the Quiver Quantitative API Congress trades endpoint.
$MDT Stock Hedge Fund Activity
We have seen 998 institutional investors add shares of $MDT Stock stock to their portfolio, and 1,327 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- CAPITAL RESEARCH GLOBAL INVESTORS removed 28,665,280 shares (-68.4%) from their portfolio in Q2 2026, for an estimated $2,242,484,854
- JPMORGAN CHASE & CO added 27,784,471 shares (+inf%) to their portfolio in Q2 2026, for an estimated $2,173,579,166
- UBS AM, A DISTINCT BUSINESS UNIT OF UBS ASSET MANAGEMENT AMERICAS LLC removed 9,106,059 shares (-93.6%) from their portfolio in Q2 2026, for an estimated $712,366,995
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 8,905,319 shares (+inf%) to their portfolio in Q2 2026, for an estimated $696,663,105
- ARROWSTREET CAPITAL, LIMITED PARTNERSHIP added 8,233,285 shares (+176.7%) to their portfolio in Q2 2026, for an estimated $644,089,885
- CAPITAL WORLD INVESTORS removed 8,134,242 shares (-49.3%) from their portfolio in Q2 2026, for an estimated $636,341,751
- SG AMERICAS SECURITIES, LLC added 6,500,749 shares (+inf%) to their portfolio in Q2 2026, for an estimated $508,553,594
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$MDT Stock Price Targets
Multiple analysts have issued price targets for $MDT recently. We have seen 17 analysts offer price targets for $MDT in the last 6 months, with a median target of $101.0.
Here are some recent targets:
- Vijay Kumar from Evercore ISI Group set a target price of $105.0 on 07/06/2026
- Mike Matson from Needham set a target price of $101.0 on 06/17/2026
- Lee Hambright from Bernstein set a target price of $97.0 on 06/05/2026
- David Roman from Goldman Sachs set a target price of $83.0 on 06/05/2026
- David Rescott from Baird set a target price of $85.0 on 06/04/2026
- Ryan Zimmerman from BTIG set a target price of $90.0 on 06/04/2026
- Joshua Jennings from TD Cowen set a target price of $119.0 on 06/04/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
